Metagenomi Therapeutics Inc
(MGX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 8,659 | 8,513 | 4,127 | 9,614 | 11,514 |
| Gross Profit | 8,659 | 8,513 | 4,127 | 9,614 | 11,514 |
| Operating Expenses | 31,498 | 29,500 | 31,947 | 30,237 | 33,897 |
| Operating Income | -22,839 | -20,987 | -27,820 | -20,623 | -22,383 |
| Other Income | 2,212 | 1,123 | 2,879 | -3,983 | 1,504 |
| Pre-tax Income | -20,627 | -19,864 | -24,941 | -24,606 | -20,879 |
| Income Tax | -234 | 44 | 98 | -1,208 | -2,106 |
| Net Income Continuous | -20,393 | -19,908 | -25,039 | -23,398 | -18,773 |
| Net Income | $-20,393 | $-19,908 | $-25,039 | $-23,398 | $-18,773 |
| EPS Basic Total Ops | -0.55 | -0.54 | -0.68 | -0.37 | -0.51 |
| EPS Basic Continuous Ops | -0.55 | -0.54 | -0.68 | -0.37 | -0.51 |
| EPS Diluted Total Ops | -0.55 | -0.54 | -0.68 | -0.37 | -0.51 |
| EPS Diluted Continuous Ops | -0.55 | -0.54 | -0.68 | -0.37 | -0.51 |
| EPS Diluted Before Non-Recurring Items | -0.55 | -0.54 | -0.68 | -0.63 | -0.45 |
| EBITDA(a) | $-22,345 | $-20,480 | $-27,546 | $-20,551 | $-24,151 |